Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study

Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries

(2019) Yukio Iwamoto et al.   BMC PUBLIC HEALTH

Menopausal hormone therapy and 20-year breast cancer mortality

(2019) Valerie Beral et al.   LANCET

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

(2019) et al.   JAMA Oncology

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update

(2018) Sharon H. Giordano et al.   JOURNAL OF CLINICAL ONCOLOGY

Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study

(2018) Usha Salagame et al.   PLoS One

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Albert L. Siu et al.   ANNALS OF INTERNAL MEDICINE

Global Cancer Incidence and Mortality Rates and Trends--An Update

(2015) L. A. Torre et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy

(2010) Barbara G. Silverman et al.   Cancer Epidemiology

Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study

(2010) T. Saxena et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Breast Cancer Incidence and Hormone Replacement Therapy in Canada

(2010) P. De et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study

(2009) V. W. Setiawan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003

(2009) Karen Canfell et al.   BREAST CANCER RESEARCH AND TREATMENT

Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?

(2009) Donald Maxwell Parkin   EUROPEAN JOURNAL OF CANCER

The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence

(2009) Helena M. Verkooijen et al.   MATURITAS

Declining breast cancer incidence and decreased HRT use

(2008) Merethe Kumle   LANCET